ஜெய் ஓல்சன் ஆபெந்ஹைமர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜெய் ஓல்சன் ஆபெந்ஹைமர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜெய் ஓல்சன் ஆபெந்ஹைமர் Today - Breaking & Trending Today

Intercept Pharmaceuticals Inc (ICPT) Q1 2021 Earnings Call Transcript

Operator
Welcome to the Q1 2021 Intercept Pharmaceuticals Earnings Call. My name is Anette, and I ll be your operator for today s call. [Operator Instructions]
I will now turn the call over to Lisa DeFrancesco. Lisa, you may begin.
Lisa DeFrancesco
Senior Vice President of Investor Relations and Corporate Affairs
Thank you. Good morning, and thank you for joining us on today s call. This morning, we issued a press release announcing our first quarter 2021 results and financial position, which is available on our website at www.interceptpharma.com. Before we begin our discussion, I d like to note that during our call, we will be making forward-looking statements, including statements regarding our approved product and clinical development program; certain regulatory matters; and our strategy, prospects, financial guidance and future commercial and financial performance. Listeners are cautioned not to place undue reliance on these forward-looking statements, w ....

United States , Gail Cawkwell , Jerome Durso , Raymond James , Chris Weyer , Linda Richardson , Steve Seedhouse , Jay Olson Oppenheimer , Lisa Defrancesco , Michael Yee , Jerry Durso , Brian Abrahams , Jay Olson , Rocco Venezia , David Cithu , Mark Pruzanski , Ryan Deschner , Piper Sandler , Jesse Piper Sandler , Navin Jacob , Ryan Deschner Raymond James , Thomas Smith , Emily Cantor Fitzgerald , Cantor Fitzgerald , Intercept Pharmaceuticals Inc , Intercept Pharmaceuticals Earnings Call ,

Exelixis Inc (EXEL) Q1 2021 Earnings Call Transcript

Operator
Good morning, ladies and gentlemen, and welcome to the Exelixis First Quarter 2021 Financial Results Conference Call. My name is Daphne, and I ll be your operator for today. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. Please proceed.
Susan T. Hubbard
Executive Vice President, Public Affairs and Investor Relations
Thank you, Daphne, and thank you all for joining us for the Exelixis First Quarter 2021 Financial Results Conference Call. Joining me on today s call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; and Gisela Schwab, our Chief Medical Officer, who together will review our corporate, financial, commercial and development progress for the first quarter 2021 ended March 31, 2021. Peter ....

United States , Asthika Goodewarne , Andy Hsieh , Stephen Willey , Susan Hubbard , Stephen Willey Stifel , Jason Gerberry , Asthika Goodewarne Truist , Mike Morrissey , Andy Hsieh William Blair , Jay Olson Oppenheimer , Kennen Mackay , Peter Lawson , Michaelm Morrissey , Jay Olson , Yaron Werber , Christopherj Senner , Chris Senner , Akash Tewari , Giselam Schwab , Paul Choi Goldman Sachs , Michael Schmidt Guggenheim , Susant Hubbard , Gabe Daoud Cowen , Gisela Schwab , Paul Choi ,

Intellia Therapeutics, Inc. (NTLA) Q1 2021 Earnings Call Transcript

Operator
Good morning. My name is Izzy and I will be your conference operator today. Welcome to the Intellia Therapeutics First Quarter 2021 Financial Results Conference Call. [Operator Instructions] [Operator Instructions]. Following formal remarks, we will open the call up for questions. This conference is being recorded at the company s request and will be available on the company s website following the end of the call.
I will now turn the conference to Lina Li, Director of Investor Relations at Intellia. Please proceed.
Lina Li
Director, Investor Relations
Thank you, operator. And Good morning, everyone. Welcome to Intellia s first quarter 2021 earnings call. Earlier today, the company issued a press release outlining the company s progress this quarter as well as topics for discussion on today s call. This release can be found on the Investors and Media section of Intellia s website at intelliatx.com. This call is being broadcast live and a replay will ....

United States , Jack Allen , Raymond James , Goldman Sachs , Gena Wang , Glenn Goddard , Joon Lee Truist , Steven Seedhouse Raymond James , Steven Seedhouse , Jay Olson Oppenheimer , David Lebwohl , Yanan Zhu , Joon Lee , Jay Olson , Sonya Goldman Sachs , Jack Allen Baird , Laura Sepp Lorenzino , Alina Li , Silvan Tuerkcan , Mani Foroohar , Maury Raycroft , Maury Raycroft Jefferies , John Leonard , European Commission , Melinda Gates Foundation , Intellia Therapeutics Inc ,

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript

Neurocrine Biosciences Inc (NBIX) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Neurocrine Biosciences Inc (NASDAQ: NBIX)
Popular Searches
Operator
Good day, everyone, and welcome to today s Neurocrine Biosciences Reports First Quarter Results. [Operator Instructions]
It is now my pleasure to turn the conference over to Vice President of Investor Relations, Todd Tushla. Please go ahead.SPONSORED:
10 stocks we like better than Neurocrine Biosciences
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , San Diego , Todd Tushla , Anupam Rama Jpmorgan , Josh Schimmer Evercore , Eiryw Roberts , Paul Matteis Stifel , Kyle Gano , Myles Minter William Blair , Phil Nadeau Cowen , Carter Gould Barclays , Josh Schimmer , Laura Chico , Matthewc Abernethy , Paul Choi , Phil Nadeau , Brian Skorney Baird , Eric Benevich , William Blair , Neena Bitritto Garg , Anupam Rama , Kevinc Gorman , Carter Gould , Marc Goodman , Laura Chico Wedbush , Jay Olson Oppenheimer ,

Incyte Corp (INCY) Q1 2021 Earnings Call Transcript

Incyte Corp (INCY) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Incyte Corp (NASDAQ: INCY)
Operator
Hello and welcome to the Incyte s First Quarter Earnings Call. [Operator Instructions] It s now my pleasure to turn the call over to Christine Chiou. Please go ahead.SPONSORED:
10 stocks we like better than Incyte
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,
Motley Fool Stock Advisor, has tripled the market.
David and Tom just revealed what they believe are the ten best stocks for investors to buy right now. and Incyte wasn t one of them! That s right they think these 10 stocks are even better buys. ....

United States , Cory Kasimov , Herve Hoppenot , Srikripa Devarakonda , Salveen Richter Goldman Sachs , Marc Frahm Cowen , Alethia Young , Jay Olson Oppenheimer , Alethia Young Cantor Fitzgerald , Vikram Purohit , Andrew Berens , Brian Abrahams , Salveen Richter , Christiana Stamoulis , Jay Olson , Marc Frahm , Matthew Phipps William Blair , Karen Benjamin , Michael Schmidt Guggenheim , Srikripa Devarakonda Truist , Reni Benjamin , Matt Phipps , Christine Chiou , Tazeen Ahmad , Michael Schmidt , Vikram Purohit Morgan Stanley ,